Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP), 51623 [E6-14441]
Download as PDF
<![CDATA[
jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 71, No. 168 / Wednesday, August 30, 2006 / Notices
reasonably necessary to obtain
significant efficiencies through the joint
arrangement.
A ‘‘qualified clinically-integrated joint
arrangement,’’ on the other hand, need
not involve any sharing of financial risk.
Instead, as defined in the proposed
order, physician participants must
participate in active and ongoing
programs to evaluate and modify their
clinical practice patterns in order to
control costs and ensure the quality of
services provided, and the arrangement
must create a high degree of
interdependence and cooperation
among physicians. As with qualified
risk-sharing arrangements, any
agreement concerning price or other
terms of dealing must be reasonably
necessary to achieve the efficiency goals
of the joint arrangement.
Paragraph III, for three years, requires
New Century and Prime Care to notify
the Commission before entering into any
arrangement to act as an agent on behalf
of any physicians, with payors regarding
contracts. Paragraph III also sets out the
information necessary to make the
notification complete.
Paragraph IV, for three years, requires
the Proposed Respondents to notify the
Commission before participating in
contracting with health plans on behalf
of a qualified risk-sharing joint
arrangement, or a qualified clinicallyintegrated joint arrangement. The
contracting discussions that trigger the
notice provision may be either among
physicians, or between New Century or
Prime Care and health plans. Paragraph
IV also sets out the information
necessary to satisfy the notification
requirement.
Paragraph V provides that, for three
years, the New Century and Prime Care
officials named in the proposed
complaint and order may not: (1)
Negotiate or act as an agent on behalf of
any physician or medical group practice
that participates or has participated in
either New Century or Prime Care; or (2)
advise any physician or medical group
practice that participates in or has
participated in either New Century or
Prime Care on contracts, offers, contract
terms, conditions, or requirements for
dealing with any payors. Exempted from
Paragraph V’s prohibition are the
officials’ participation in: (1) Certain
qualified risk-sharing joint
arrangements; (2) certain qualified
clinically-integrated joint arrangements;
and (3) activities that solely involve
physicians in a medical group practice
in which the official participates.
For three years, Paragraph VI requires
both New Century and Prime Care,
respectively, to distribute the complaint
and order: (1) To all physicians who
VerDate Aug<31>2005
16:39 Aug 29, 2006
Jkt 208001
have participated in the IPAs, who
currently participate in the IPAs, or who
express interest in participating in the
IPAs; and (2) to payors that have
negotiated contracts with the IPAs, or
that contract with the IPAs in the future.
Paragraphs VII, VIII, IX, and X of the
proposed order impose various
obligations on the Proposed
Respondents to report or provide access
to information to the Commission to
facilitate the monitoring of compliance
with the order. Paragraph XI provides
that the proposed order will expire in 20
years.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. E6–14360 Filed 8–29–06; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Childhood
Lead Poisoning Prevention (ACCLPP)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC), National
Center for Environmental Health
(NCEH) announces the following
committee meeting.
Name: Advisory Committee on
Childhood Lead Poisoning Prevention
(ACCLPP).
Times and Dates: October 17, 2006,
8:30 a.m.–5 p.m., October 18, 2006, 8:30
a.m.–12:30 p.m.
Place: Hilton St. Louis at the Ballpark,
One South Broadway, St. Louis, MO
63102, Telephone: 314 421–1776 or Toll
free 1–877–845–7354.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 75
people.
Purpose: The Committee provides
advice and guidance to the Secretary;
the Assistant Secretary for Health; and
the Director, CDC, regarding new
scientific knowledge and technological
developments and their practical
implications for childhood lead
poisoning prevention efforts. The
committee also reviews and reports
regularly on childhood lead poisoning
prevention practices and recommends
improvements in national childhood
lead poisoning prevention efforts.
Matters To Be Discussed: Update on
the Lead and Pregnancy Workgroup
activities, update on the clinical
implications of blood lead levels (BLL)
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
51623
less than 10 and discussions of
laboratory capacity to analyze BLL <2
µg/dL. Agenda items are subject to
change as priorities dictate.
Opportunities will be provided during
the meeting for oral comments.
Depending on the time available and the
number of requests, it may be necessary
to limit the time of each presenter.
For Further Information Contact:
Claudine Johnson, Clerk, (Contractor)
Lead Poisoning Prevention Branch,
Division of Environmental Emergency
Health Services, NCEH, CDC, 4770
Buford Hwy., NE., Mailstop F–40,
Atlanta, GA 30341, telephone 770 488–
3629,fax 770 488–3635.
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: August 22, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–14441 Filed 8–29–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: State-Based
Occupational Safety and Health
Surveillance and Occupational Health
and Safety Research, Request for
Application (RFA) PAR–04–106; and
Occupational Health and Safety
Research, RFA PAR–04–038
Correction: This notice was published
in the Federal Register on August 17,
2006, Volume 71, Number 159, page
47498. The meeting has been changed to
reflect an additional Request for
Applications.
Title: State-Based Occupational Safety
and Health Surveillance and
Occupational Health and Safety
Research, RFA PAR–04–106; and
Occupational Health and Safety
Research, RFA PAR–04–038.
Contact Person for More Information:
M. Chris Langub, Scientific Review
Administrator, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1600 Clifton Road NE, MS E–74,
E:\FR\FM\30AUN1.SGM
30AUN1
]]>Agencies
[Federal Register Volume 71, Number 168 (Wednesday, August 30, 2006)]
[Notices]
[Page 51623]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-14441]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Childhood Lead Poisoning Prevention
(ACCLPP)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), National Center for Environmental Health (NCEH)
announces the following committee meeting.
Name: Advisory Committee on Childhood Lead Poisoning Prevention
(ACCLPP).
Times and Dates: October 17, 2006, 8:30 a.m.-5 p.m., October 18,
2006, 8:30 a.m.-12:30 p.m.
Place: Hilton St. Louis at the Ballpark, One South Broadway, St.
Louis, MO 63102, Telephone: 314 421-1776 or Toll free 1-877-845-7354.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 75 people.
Purpose: The Committee provides advice and guidance to the
Secretary; the Assistant Secretary for Health; and the Director, CDC,
regarding new scientific knowledge and technological developments and
their practical implications for childhood lead poisoning prevention
efforts. The committee also reviews and reports regularly on childhood
lead poisoning prevention practices and recommends improvements in
national childhood lead poisoning prevention efforts.
Matters To Be Discussed: Update on the Lead and Pregnancy Workgroup
activities, update on the clinical implications of blood lead levels
(BLL) less than 10 and discussions of laboratory capacity to analyze
BLL <2 [mu]g/dL. Agenda items are subject to change as priorities
dictate.
Opportunities will be provided during the meeting for oral
comments. Depending on the time available and the number of requests,
it may be necessary to limit the time of each presenter.
For Further Information Contact: Claudine Johnson, Clerk,
(Contractor) Lead Poisoning Prevention Branch, Division of
Environmental Emergency Health Services, NCEH, CDC, 4770 Buford Hwy.,
NE., Mailstop F-40, Atlanta, GA 30341, telephone 770 488-3629,fax 770
488-3635.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: August 22, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E6-14441 Filed 8-29-06; 8:45 am]
BILLING CODE 4163-18-P
